BROWN BROTHERS HARRIMAN & CO - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
BROWN BROTHERS HARRIMAN & CO ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$13,743
-5.5%
3810.0%0.00%
Q1 2023$14,550
-32.9%
3810.0%0.00%
Q4 2022$21,679
-32.3%
381
-52.4%
0.00%
Q3 2022$32,000
-8.6%
8010.0%0.00%
Q2 2022$35,000
+483.3%
801
+134.2%
0.00%
Q4 2019$6,000
+20.0%
3420.0%0.00%
Q3 2019$5,0003420.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders